Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug and method for treating rheumatism and lumbar intervertebral disc herniation

A technology of lumbar disc herniation and drugs, which is applied in the field of drugs for the treatment of rheumatism and lumbar disc herniation, and can solve the problems of easy recurrence, spinal nerve root stimulation or compression, and high cost

Active Publication Date: 2018-02-27
王应江
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Lumbar disc herniation is one of the more common diseases, mainly because various parts of the lumbar intervertebral disc (nucleus pulposus, annulus fibrosus, and cartilage plate), especially the nucleus pulposus, have degenerative changes to varying degrees, and under the action of external forces , the annulus fibrosus of the intervertebral disc ruptures, and the nucleus pulposus protrudes (or protrudes) from the rupture to the rear or in the spinal canal, causing irritation or compression of the adjacent spinal nerve roots, resulting in low back pain, numbness and pain in one or both lower limbs and a series of clinical symptoms; the existing treatment is divided into surgical treatment and non-surgical treatment. Non-surgical treatment is mainly aimed at patients with mild symptoms, and the cure is slow. , Percutaneous transforaminal endoscopic intervertebral disc removal and other minimally invasive surgical techniques reduce surgical damage and achieve good results, but the cost is high and recurrence is easy
[0008] However, there is no good treatment for the sequelae of cerebral thrombosis and hemiplegia. Rehabilitation treatment is often used now, and the effect is relatively slow.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Embodiment 1: Get 30g parts of black ants, 25g of soil element, 50g of Yanma Sang, 50g of Rhizoma Rhizoma Rhizoma Rhizoma Rhizoma Rhizome, 8g of Asarum, 25g of Shenjincao, 25g of Passepartout, 25g of Sperantospermia and 25g of Dilonga, put into Put it in a wine jar with 20kg of corn wine, and seal the wine jar, store it for half a month before taking it; take 3-5 yuan each time, twice a day.

Embodiment 2

[0029] Embodiment 2: get black ant 60g, soil element 35g, rock horse mulberry 70g, drynaria rhizome 70g, scalloped asarum 12g, shenjincao 35g, Passepartout 35g, Speranthus 35g and earthworm 35g and put into the container Put 20kg of corn wine in the wine jar, and seal the wine jar, store it for half a month before taking it; take 3-5 yuan each time, twice a day.

Embodiment 3

[0030] Embodiment 3: get black ant 45g, soil element 30g, rock horse mulberry 60g, rhizoma drynaria 60g, vetch leaf asarum 10g, shenjincao 30g, Passepartout 30g, Speranthema 30g and earthworm 30g drop into Put 20kg of corn wine in the wine jar, and seal the wine jar, store it for half a month before taking it; take 3-5 yuan each time, twice a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating rheumatism and lumbar disc protrusion and a production method thereof. The medicine is prepared from the following raw materials in parts by weight: 30-60 parts of black ant, 25-35 parts of ground beetle, 50-70 parts of chimonanthus nitens, 50-70 parts of rhizoma drynariae, 8-12 parts of asarum insigne Diels, 25-35 parts of herba lycopodii, 25-35 parts of fructus liquidambaris, 25-35 parts of trberculate speranskia herb and 25-35 parts of pheretima. The medicines employs the treatment fundament of unblocking meridian and activating collaterals, dispelling wind and eliminating dampness, activating blood and resolving stasis, dispersing swelling and relieving pain. Corn wine is employed to assist to the medicine effectiveness to directly reach nidus, and the bulk drugs together give play to magical effect. Clinical verification for more than ten years prove that the medicine has no any toxic and side effects for treating more than five thousands of patients.

Description

technical field [0001] The invention relates to a medicine for treating rheumatism and lumbar intervertebral disc herniation and a method thereof, belonging to the technical field of Chinese herbal medicines. Background technique [0002] Rheumatic diseases are a class of autoimmune diseases that invade multiple tissues, systems and internal organs. Different degrees of immune inflammatory response can cause damage to various tissues and organs, seriously affect their normal functions, and even cause fatal damage. Existing drugs for the treatment of rheumatic diseases can be divided into the following categories: [0003] 1. Non-steroidal anti-inflammatory drugs (NSAIDs): The effects of these drugs are mainly antipyretic, anti-inflammatory and analgesic, so as to reduce the inflammatory response and purpose. Aspirin (acetylsalicylic acid) is the earliest and is still an effective drug for the treatment of acute rheumatic fever and rheumatoid arthritis. Various salicylic a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/47A61K36/268A61K36/8945A61P29/00A61P19/08A61K35/62A61K35/64
Inventor 王应江
Owner 王应江
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products